Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
West Pharmaceutical Services, Inc. (WST)
Market Closed
16 Oct, 08:00 PM
NYSE
All
(9)
DE
(5)
IT
(1)
GB
(1)
MX
(1)
US
(1)
NYSE
Primary
XHAN
XFRA
XDUS
XSTU
XMUN
XMEX
LSE
XMIL
$
384.
02
+1
+0.2611%
$
26.96B
Market Cap
49.01
P/E Ratio
0.88%
Div Yield
511,200
Volume
7.62
Eps
$
383.02
Previous Close
Investors:
TJD
LC
BZ
+207
Watching
Watch
Add Transaction
Day Range
380.28
386.26
Year Range
223.83
386.26
Want to track
WST
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
West Pharmaceutical Services, Inc. (WST) Statistics
Valuation metrics
Market Cap
26.96B
Enterprise value
26.9B
Trailing P/E (ttm)
48.8
Forward P/E
26.62
PEG ratio
2.85
Price/Sales (ttm)
8.12
Price/Book (mrq)
9.09
Enterprise Value/Revenue
8.09
Enterprise Value/EBITDA
30.91
Overview
Shares outstanding
72.04M
Float
71.52M
Shares short
2.37M
% Held by insiders
0.01%
% Held by institutions
0.98%
Average volume (10 days)
448.88K
Average volume (90 days)
612.88K
Price summary
52-Week low
223.83
52-Week high
386.26
Beta
1.18
50-Day moving average
361.45
200-Day moving average
332.77
Dividends and splits
Forward annual dividend rate
0.88
Forward annual dividend yield
0.0037%
Trailing annual dividend rate
0.88
Trailing annual dividend yield
0.0023%
5-Year annual dividend yield
0.25%
Payout ratio
0.11
Dividend Date
5 Aug 2026
Ex-Dividend Date
29 Jul 2026
Last split factor
2:1
Last split Date
27 Sep 2013
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.17%
Operating margin
0.21%
Operational effectiveness
Return on assets
0.14%
Return on equity
0.19%
Income Statement
Revenue (ttm)
3.07B
Revenue per share (ttm)
46.98
Quarterly revenue growth (yoy)
0.07%
Gross profit (ttm)
1.1B
EBITDA
822.7M
Net income to common (ttm)
493.7M
Diluted EPS (ttm)
7.98
Quarterly earnings growth (yoy)
0.01%
Balance Sheet
Total cash (mrq)
791.3M
Total cash per share (mrq)
6.16
Total debt (mrq)
326.2M
Total Debt/Equity (mrq)
0.1
Current ratio (mrq)
2.82%
Book value per share (mrq)
42.23
Cash Flow
Cash flow statement
754.8M
Levered free cash flow (LFCF)
273.88M